34. 神経線維腫症
[臨床試験数:120,薬物数:182(DrugBank:72),標的遺伝子数:84,標的パスウェイ数:194]
Searched query = "Neurofibromatosis", "NF1", "von Recklinghausen disease", "NF2"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT03231306 (ClinicalTrials.gov) | November 28, 2017 | 21/7/2017 | Phase II Study of Binimetinib in Children and Adults With NF1 Plexiform Neurofibromas | A Phase II Study of Binimetinib in Children and Adults With NF1 Associated Plexiform Neurofibromas (PNOC010) | Neurofibromatosis Type 1;Plexiform Neurofibroma | Drug: Binimetinib | University of Alabama at Birmingham | Array BioPharma;Pacific Pediatric Neuro-Oncology Consortium | Recruiting | 1 Year | N/A | All | 40 | Phase 2 | United States |